Propofol-remifentanil or propofol-ketamine for burn care in pediatric patients
Not Applicable
Recruiting
- Conditions
- Injury, poisoning and certain other consequences of external causes
- Registration Number
- KCT0001113
- Lead Sponsor
- Bestian Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Patients scheduled for burn care under sedation are included.
Exclusion Criteria
Patients are excluded if they have a cardiovascular, cerebrovascular, pulmonary, renal or hepatic disease, or are at risk of aspiration.
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sedation score;Recovery time
- Secondary Outcome Measures
Name Time Method the incidence of hypotension, bradycardia, respiratory depression, hypoxia;the requirement of additional drugs;Nausea and vomiting ;restlessness or agitation
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of propofol-remifentanil and propofol-ketamine in pediatric burn pain management?
How does propofol-remifentanil compare to propofol-ketamine in managing burn-related analgesia in children?
Are there specific biomarkers that predict analgesic response to propofol-based sedation in pediatric burn patients?
What are the potential adverse events associated with propofol-remifentanil versus propofol-ketamine in pediatric burn care?
What alternative sedation strategies are being explored for pediatric burn treatment alongside propofol-based regimens?